One-pot synthesis of 5-amino 4-cyano pyrrole derivatives

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Tetrahedron Letters

• Publication date

  2011-05-25

• Fields of study

  Chemistry

• Identifiers
  DOI 10.1016/J.TETLET.2011.03.080
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Convenient synthesis of 4-tert-butyl 2-ethyl 3-amino-1-benzyl-5-dialkylamino-1H-pyrrole-2,4-dicarboxylate derivatives

  2011cited by this paper
• Discovery of new chemotype dipeptidyl peptidase IV inhibitors having (R)-3-amino-3-methyl piperidine as a pharmacophore.

  2010cited by this paper
• Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes.

  2009cited by this paper
• Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV.

  2007cited by this paper
• Paal—Knorr Reaction for Novel Pyrrolo[2,3-d]pyrimidines.

  2006cited by this paper
• Sitagliptin: A Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

  2006cited by this paper
• Discovery and preclinical profile of Saxagliptin (BMS-477118): a highly potent, long-acting, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

  2005cited by this paper
• Regioselectivity in the reactions of polyfunctionalised pyrroles with nucleophiles

  2005cited by this paper
• Glucagon-like peptide-1: physiology and therapeutic potential

  2005cited by this paper
• (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: a potent, orally active dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

  2005cited by this paper
• Pyrrolodiazines. 6. Palladium-catalyzed arylation, heteroarylation, and amination of 3,4-dihydropyrrolo[1,2-a]pyrazines.

  2004cited by this paper
• Glucagon-like peptide-1: the basis of a new class of treatment for type 2 diabetes.

  2004cited by this paper
• Circulation and Degradation of GIP and GLP-1

  2004cited by this paper
• Palladium-catalysed amination of 2-acyl-1-alkyl-5-bromopyrroles

  2004cited by this paper
• 1-[[(3-hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(S)-pyrrolidine: a potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitor with antihyperglycemic properties.

  2003cited by this paper
• Cycloaddition of New N-Unsubstituted Azomethine Ylides Generated from N-(Trimethylsilylmethyl)thioureas to Electron-Deficient Olefins, Acetylenes and Aldehydes, Synthetic Equivalents of Nonstabilized Aminonitrile Ylides 1

  2000cited by this paper
• Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV.

  1995cited by this paper
• Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum.

  1993cited by this paper

• Synthesis and evaluation of novel spiro derivatives for pyrrolopyrimidines as anti-hyperglycemia promising compounds

  2018cites this paper
• Five-Membered Ring Systems: Pyrroles and Benzo Analogs

  2012cites this paper
• One-Pot Synthesis of 5-Amino-4-cyano Pyrrole Derivatives.

  2011cites this paper